Pfizer-BioNTech COVID-19 vaccine risk of Omicron infection among children: CDC

Pfizer-BioNTech COVID-19 vaccine risk of Omicron infection among children: CDC

Pfizer-BioNTech COVID-19 vaccine risk of Omicron infection among children: CDC

pfizer said government was involved in the fruad

Advertisement

WASHINGTON – Two doses of Pfizer-BioNTech COVID-19 vaccine greatly reduced the risk of Omicron infection among children aged 5 to 15, according to a study published by the U.S. Centers for Disease Control and Prevention (CDC) on Friday.

Children and adolescents aged 5 to 15 were tested for SARS-CoV-2 weekly, irrespective of symptoms, during July 2021 to February 2022, according to the CDC.

Approximately one half of Omicron infections in unvaccinated children and adolescents were asymptomatic, according to the CDC.

Read more: Pfizer seeks US approval of Covid vaccine for children under 5

Advertisement

Two doses of Pfizer-BioNTech COVID-19 vaccine reduced the risk of Omicron infection by 31 percent among children aged 5 to 11, and by 59 percent among adolescents aged 12 to 15, according to the CDC study.

The Pfizer-BioNTech mRNA COVID-19 vaccine was recommended by CDC’s Advisory Committee on Immunization Practices for adolescents aged 12 to 15 on May 12 last year, and for children aged 5 to 11 years on Nov. 2.

 

Advertisement
Advertisement
Read More News On

Catch all the Health News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Follow us on Google News.


End of Article
Advertisement
In The Spotlight Popular from Pakistan Entertainment
Advertisement

Next Story